HOLLY DORNETTE: Open Payments
NPI 1669910303 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 17 payments from 10 companies in 2025. Trend: 2023 $142 · 2024 $520 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $227 |
| Gilead Sciences, Inc. | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| TAIHO ONCOLOGY, INC. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| GENZYME CORPORATION | 1 | $17 |
| TerSera Therapeutics LLC | 1 | $14 |
| PFIZER INC. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: SCEMBLIX, Trodelvy, ENHERTU, KISQALI, LONSURF, KEYTRUDA, OJJAARA, ALTUVIIIO.
Industry payments across OH — which companies pay providers there.
